ÂÜÀòÂÒÂ×

Kristina Fetalvero has over 10 years of experience in the biotechnology industry. Kristina began their career in 2009 as a Presidential Postdoctorate Fellow at Novartis Institutes for BioMedical Research (NIBR). In 2012, they joined Ember Therapeutics as a Scientist. From 2015 to 2016, they worked as a Senior Scientist at Navitor Pharmaceuticals. Kristina then moved to Blueprint Medicines, where they held the roles of Senior Scientist I, Senior Scientist II, and Principal Scientist. In 2020, they began working as a Consultant at Third Rock Ventures and as a Principal Scientist at MOMA Therapeutics.

Kristina Fetalvero received their B.S. in Biology from the University of San Francisco in 2002, and went on to earn their PhD in Pharmacology and Toxicology from Dartmouth College in 2008.